Cited by 866Liver physiology and pathologyWound Healing and TreatmentsLiver Disease Diagnosis and Treatment

The DOI matches its Crossref record; 126 of the 128 references it cites were found in a registry or an index.

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

Open access

Iredale, John P.·2007·Journal of Clinical Investigation

Open this paper in CoChat — free account Open PDF

Abstract

Models of liver fibrosis, which include cell culture models, explanted and biopsied human material, and experimental animal models, have demonstrated that liver fibrosis is a highly dynamic example of solid organ wound healing. Recent work in human and animal models has shown that liver fibrosis is potentially reversible and, in specific circumstances, demonstrates resolution with a restoration of near normal architecture. This Review highlights the manner in which studies of models of liver fibrosis have contributed to the paradigm of dynamic wound healing in this solid organ.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci30542

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Molecular Mechanisms of Stress-Responsive Changes in Collagen and Elastin Networks in Skin
Aziz, J., Shezali, H., Radzi, Z., Yahya, N. A., Abu Kassim, N. H., Czernuszka, J., & Rahman, M. T. (2016) · Skin Pharmacology and Physiology · doi:10.1159/000447017 · Cited by 7,323
Liver fibrosis
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
The Versatile Role of microRNA-30a in Human Cancer
Wang, C., Yang, X., Chen, Y., & Chen, L. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000471111 · Cited by 3,414
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF.
Fadok, V. A., Bratton, D. L., Konowal, A., Freed, P. W., Westcott, J. Y., & Henson, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1112 · Cited by 3,166
Nonalcoholic Steatohepatitis
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci20530 · Cited by 2,715
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
Friedman, S. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.4.2247 · Cited by 2,067
Liver fibrosis – from bench to bedside
Friedman, S. L. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00429-4 · Cited by 1,780
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair
Duffield, J. S., Forbes, S. J., Constandinou, C. M., Clay, S., Partolina, M., Vuthoori, S., Wu, S., Lang, R., & Iredale, J. P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200522675 · Cited by 1,649
Self-citation
Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes
Álvarez‐Dolado, M., Pardal, R., García‐Verdugo, J. M., Fike, J. R., Lee, H. O., Pfeffer, K., Lois, C., Morrison, S. J., & Álvarez-Buylla, A. (2003) · Nature · doi:10.1038/nature02069 · Cited by 1,617

Show all 128 references

Research works printed but not linked: 9

10.1172/JCI200524282 · DOI · Paper page
Otto, 1980, Adv. Exp. Med. Biol., 132, 509
Constandinou, 2005, Methods Mol. Med., 117, 237
Montfort, 1978, Am. J. Pathol., 92, 411
Jeong, 2002, Anticancer Res., 22, 869
Okazaki, 1998, Lab. Invest., 78, 1431
10.1172/JCI200320530 · DOI
10.1053/gast.1996.v110.pm8608892 · DOI · Paper page
10.1074/jbc.275.4.2247 · DOI

Sorted by citations

Items 101–200 of 865

Insights into Manganese Superoxide Dismutase and Human Diseases
Liu, M., Sun, X., Chen, B., Dai, R., Xi, Z., & Xu, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232415893 · Cited by 157
Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice
Ganz, M., Bukong, T. N., Csák, T., Saha, B., Park, J., Ambade, A., Kodys, K., & Szabó, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0552-7 · Cited by 149
Direct and Indirect Contribution of Human Embryonic Stem Cell–Derived Hepatocyte-Like Cells to Liver Repair in Mice
Woo, D., Kim, S., Lim, H., Heo, J., Park, H. S., Kang, G., Kim, S. E., You, H., Hoeppner, D. J., Kim, Y., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.11.030 · Cited by 147
Macrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis
Popov, Y., Sverdlov, D. Y., Bhaskar, K. R., Sharma, A. K., Millonig, G., Patsenker, E., Krahenbuhl, S., Krahenbuhl, L., & Schuppan, D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00394.2009 · Cited by 136
Reversibility of liver fibrosis
Pellicoro, A., Ramachandran, P., & Iredale, J. P. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-s1-s26 · Cited by 135
Self-citation
Chemokine-directed immune cell infiltration in acute and chronic liver disease
Karlmark, K. R., Wasmuth, H. E., Trautwein, C., & Tacke, F. (2008) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2.2.233 · Cited by 137
Inhibition of fibronectin deposition improves experimental liver fibrosis
Altrock, E., Sens, C., Würfel, C., Vasel, M., Kawelke, N., Dooley, S., Sottile, J., & Nakchbandi, I. A. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.06.010 · Cited by 136
The characteristics of activated portal fibroblasts/myofibroblasts in liver fibrosis
Karin, D., Koyama, Y., Brenner, D. A., & Kisseleva, T. (2016) · Differentiation · doi:10.1016/j.diff.2016.07.001 · Cited by 138
CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation
Hintermann, E., Bayer, M., Pfeilschifter, J. M., Luster, A. D., & Christen, U. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.09.003 · Cited by 135
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
Thabet, K., Asimakopoulos, A., Shojaei, M., Romero‐Gómez, M., Mangia, A., Irving, W. L., Berg, T., Dore, G. J., Grønbæk, H., Sheridan, D. A., et al. (2016) · Nature Communications · doi:10.1038/ncomms12757 · Cited by 130
The etiology of liver damage imparts cytokines transforming growth factor β1 or interleukin-13 as driving forces in fibrogenesis #
Weng, H., Liu, Y., Chen, J., Huang, T., Xu, L., Godoy, P., Hu, J.-H., Zhou, C., Stickel, F., Marx, A., et al. (2009) · Hepatology · doi:10.1002/hep.22934 · Cited by 131
Mechanisms for the Resolution of Organ Fibrosis
Horowitz, J. C., & Thannickal, V. J. (2018) · Physiology · doi:10.1152/physiol.00033.2018 · Cited by 135
New Insights into Nephrogenic Systemic Fibrosis
Swaminathan, S., & Shah, S. V. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007060645 · Cited by 129
Angiotensin II Activates IκB Kinase Phosphorylation of RelA at Ser536 to Promote Myofibroblast Survival and Liver Fibrosis
Oakley, F., Teoh, V. W. Y., Ching-A-Sue, G., Bataller, R. A., Colmenero, J., Jonsson, J. R., Eliopoulos, A. G., Watson, M. R., Manas, D., & Mann, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.081 · Cited by 127
Anti‐fibrotic effect of chorionic plate‐derived mesenchymal stem cells isolated from human placenta in a rat model of CCl4‐injured liver: Potential application to the treatment of hepatic diseases
Lee, M., Jung, J., Na, K., Moon, J. S., Lee, H., Kim, J., Kim, G. I., Kwon, S., Hwang, S., & Kim, G. J. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22873 · Cited by 127
Stabilin-1 expression defines a subset of macrophages that mediate tissue homeostasis and prevent fibrosis in chronic liver injury
Rantakari, P., Patten, D. A., Valtonen, J., Karikoski, M., Gerke, H., Dawes, H., Laurila, J., Ohlmeier, S., Elima, K., Hübscher, S. G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1604780113 · Cited by 119
Retinoic Acid Signaling Sensitizes Hepatic Stellate Cells to NK Cell Killing via Upregulation of NK Cell Activating Ligand RAE1
Radaeva, S., Wang, L., Radaev, S., Jeong, W.-I., Park, O., & Gao, B. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00212.2007 · Cited by 123
Poly (ADP-Ribose) Polymerase-1 Is a Key Mediator of Liver Inflammation and Fibrosis
Mukhopadhyay, P., Rajesh, M., Cao, Z., Horváth, B., Park, O., Wang, H., Erdélyi, K., Holovac, E., Wang, Y., Liaudet, L., et al. (2013) · Hepatology · doi:10.1002/hep.26763 · Cited by 125
The lens as a model for fibrotic disease
ELDRED, J., Dawes, L. J., & Wormstone, I. M. (2011) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2010.0341 · Cited by 130
Update on the pathophysiology of liver fibrosis
Pinzani, M., & Macías‐Barragán, J. (2010) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.10.47 · Cited by 126
Therapeutic targets in liver fibrosis
Fallowfield, J. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00451.2010 · Cited by 123
Biomarker-Based Approaches for Assessing Alcohol Use Disorders
Niemelä, O. J. (2016) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph13020166 · Cited by 131
Viscoelasticity Measurement in Rat Livers Using Shear-Wave US Elastography
Sugimoto, K., Moriyasu, F., Oshiro, H., Takeuchi, H., Yoshimasu, Y., Kasai, Y., Furuichi, Y., & Itoi, T. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.05.008 · Cited by 123
Exosomal miR‐103‐3p from LPS‐activated THP‐1 macrophage contributes to the activation of hepatic stellate cells
Chen, L., Yao, X., Yao, H., Ji, Q., Ding, G., & Liu, X. (2020) · The FASEB Journal · doi:10.1096/fj.201902307rrr · Cited by 124
Regulation of myofibroblast activities: Calcium pulls some strings behind the scene
Castella, L. F., Gabbiani, G., McCulloch, C. A., & Hinz, B. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.04.033 · Cited by 124
Novel therapeutic targets in primary biliary cirrhosis
Dyson, J. K., Hirschfield, G. M., Adams, D. H., Beuers, U., Mann, D. A., Lindor, K. D., & Jones, D. E. J. (2015) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.12 · Cited by 120
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo
Jiang, J. X., Venugopal, S. K., Serizawa, N., Chen, X., Scott, F., Li, Y., Adamson, R. H., Devaraj, S., Shah, V. H., Gershwin, M. E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.074 · Cited by 120
Inhibition by curcumin of multiple sites of the transforming growth factor-beta1 signalling pathway ameliorates the progression of liver fibrosis induced by carbon tetrachloride in rats
Yao, Q., Xu, B., Wang, J., Liu, H., Zhang, S., & Tu, C. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-156 · Cited by 120
Ectopic SOX9 Mediates Extracellular Matrix Deposition Characteristic of Organ Fibrosis
Hanley, K. P., Oakley, F., Sugden, S. A., Wilson, D. I., Mann, D. A., & Hanley, N. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707390200 · Cited by 117
Transcriptional regulation of hepatic stellate cells
Mann, J., & Mann, D. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.03.011 · Cited by 119
Protective Effect of Astaxanthin on Liver Fibrosis through Modulation of TGF- β 1 Expression and Autophagy
Shen, M., Chen, K., Lu, J., Cheng, P., Xu, L., Dai, W., Wang, F., He, L., Zhang, Y., Wang, C., et al. (2014) · Mediators of Inflammation · doi:10.1155/2014/954502 · Cited by 117
Silent information regulator 1 (SIRT1) ameliorates liver fibrosis via promoting activated stellate cell apoptosis and reversion
Wu, Y., Liu, X., Zhou, Q. Y., Huang, C., Meng, X., Xu, F., & Li, J. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.028 · Cited by 117
Platelets contribute to the reduction of liver fibrosis in mice
Watanabe, M., Murata, S., Hashimoto, I., Nakano, Y., Ikeda, O., Aoyagi, Y., Matsuo, R., Fukunaga, K., Yasue, H., & Ohkohchi, N. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05497.x · Cited by 115
Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models
Dai, H., Zhu, C., Huai, Q., Xu, W., Zhu, J., Zhang, X., Zhang, X., Sun, B., Xu, H., Zheng, M., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.034 · Cited by 114
Molecular MR imaging of liver fibrosis: A feasibility study using rat and mouse models
Polášek, M., Fuchs, B. C., Uppal, R., Schühle, D. T., Alford, J. K., Loving, G. S., Yamada, S., Wei, L., Lauwers, G. Y., Guimarães, A. R., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.04.035 · Cited by 113
Fontan-associated liver disease: Implications for heart transplantation
Greenway, S. C., Crossland, D. S., Hudson, M., Martin, S. R., Myers, R. P., Prieur, T., Hasan, A., & Kirk, R. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.015 · Cited by 113
Targeted delivery of hyaluronic acid nanomicelles to hepatic stellate cells in hepatic fibrosis rats
Li, W., Zhou, C., Fu, Y. S., Chen, T., Liu, X., Zhang, Z., & Gong, T. (2019) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2019.07.003 · Cited by 119
Liver sinusoidal endothelial cells (LSECs) function and NAFLD; NO-based therapy targeted to the liver
Kuś, E., Gregorius, A., & Chłopicki, S. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.04.010 · Cited by 118
IL-13 Induces Connective Tissue Growth Factor in Rat Hepatic Stellate Cells via TGF-β–Independent Smad Signaling
Liu, Y., Meyer, C., Müller, A., Herweck, F., Li, Q., Müllenbach, R., Mertens, P. R., Dooley, S., & Weng, H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003260 · Cited by 111
The stellate cell system (vitamin A-storing cell system)
Senoo, H., Mezaki, Y., & Fujiwara, M. (2017) · Anatomical Science International · doi:10.1007/s12565-017-0395-9 · Cited by 112
Hepatic myofibroblasts: A heterogeneous population of multifunctional cells in liver fibrogenesis
Novo, E., di Bonzo, L. V., Cannito, S., Colombatto, S., & Parola, M. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.010 · Cited by 108
Liver fibrosis: a bidirectional model of fibrogenesis and resolution
Ramachandran, P., & Iredale, J. P. (2012) · QJM · doi:10.1093/qjmed/hcs069 · Cited by 113
Self-citation
Chlorogenic Acid Inhibits Liver Fibrosis by Blocking the miR-21-Regulated TGF-β1/Smad7 Signaling Pathway in Vitro and in Vivo
Yang, F., Luo, L., Zhu, Z., Zhou, X., Wang, Y., Xue, J., Zhang, J., Cai, X., Chen, Z.-L., Ma, Q., et al. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00929 · Cited by 107
Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential #
Moles, A., Tarrats, N., Fernández-Checa, J. C., & Marı́, M. (2008) · Hepatology · doi:10.1002/hep.22753 · Cited by 108
Reversibility of Liver Fibrosis and Inactivation of Fibrogenic Myofibroblasts
Liu, X., Xu, J., Brenner, D. A., & Kisseleva, T. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0018-7 · Cited by 108
Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease
Marsillach, J., Camps, J., Ferré, N., Beltrán‐Debón, R., Rull, A., Mackness, B., Mackness, M., & Joven, J. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-3 · Cited by 105
Recent advances in understanding liver fibrosis: bridging basic science and individualized treatment concepts
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2018) · F1000Research · doi:10.12688/f1000research.14841.1 · Cited by 106
Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury
Liang, B. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i17.5271 · Cited by 103
Liver function tests in identifying patients with liver disease
Ahmed, Z., Ahmed, U. S., Walayat, S., Ren, J., Martin, D. K., Moole, H. V., Koppe, S., Yong, S. L., & Dhillon, S. (2018) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s160537 · Cited by 103
Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine‐induced hepatic fibrosis in mice
Latella, G., Vetuschi, A., Sferra, R., Catitti, V., D’Angelo, A., Zanninelli, G., Flanders, K. C., & Gaudio, E. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02011.x · Cited by 106
Immune Interactions in Hepatic Fibrosis
Holt, A. P., Salmon, M., Buckley, C. D., & Adams, D. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.002 · Cited by 104
Repair‐related activation of hedgehog signaling promotes cholangiocyte chemokine production†
Omenetti, A., Syn, W., Jung, Y., Francis, H., Porrello, A., Witek, R. P., Choi, S. S., Yang, L., Mayo, M. J., Gershwin, M. E., et al. (2009) · Hepatology · doi:10.1002/hep.23019 · Cited by 101
Prospective comparison of transient, point shear wave, and magnetic resonance elastography for staging liver fibrosis
Lefebvre, T. L., Wartelle‐Bladou, C., Wong, P. Y. N., Sebastiani, G., Giard, J., Castel, H., Murphy-Lavallée, J., Olivié, D., Ilinca, A. P., Sylvestre, M., et al. (2019) · European Radiology · doi:10.1007/s00330-019-06331-4 · Cited by 100
Hepatic Localization of Macrophage Phenotypes during Fibrogenesis and Resolution of Fibrosis in Mice and Humans
Beljaars, L., Schippers, M., Reker‐Smit, C., Martínez, F. O., Helming, L., Poelstra, K., & Melgert, B. N. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00430 · Cited by 101
Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells
Jin, Z., Sun, R., Wei, H., Gao, X., Chen, Y., & Tian, Z. (2010) · Hepatology · doi:10.1002/hep.23983 · Cited by 104
Reversibility of liver fibrosis
Ramachandran, P., & Iredale, J. P. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31740-5 · Cited by 99
Self-citation
Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats
Wang, Y., Lian, F., Li, J., Fan, W., Xu, H., Yang, X., Liang, L., Chen, W., & Yang, J. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-133 · Cited by 98
IFN-λ3, not IFN-λ4, likely mediates IFNL3–IFNL4 haplotype–dependent hepatic inflammation and fibrosis
Eslam, M., McLeod, D. J., Kelaeng, K. S., Mangia, A., Berg, T., Thabet, K., Irving, W. L., Dore, G. J., Sheridan, D. A., Grønbæk, H., et al. (2017) · Nature Genetics · doi:10.1038/ng.3836 · Cited by 98
Pro-fibrotic compounds induce stellate cell activation, ECM-remodelling and Nrf2 activation in a human 3D-multicellular model of liver fibrosis
Prestigiacomo, V., Weston, A. A., Messner, S., Lampart, F. L., & Suter‐Dick, L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179995 · Cited by 102
Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis
Schon, H.-T., Bartneck, M., Borkham-Kamphorst, E., Nattermann, J., Lammers, T., Tacke, F., & Weiskirchen, R. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00033 · Cited by 97
Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans
Pritchett, J. P., Harvey, E., Athwal, V. S., Berry, A. A., Rowe, C., Oakley, F., Moles, A., Mann, D. A., Bobola, N., Sharrocks, A. D., et al. (2012) · Hepatology · doi:10.1002/hep.25758 · Cited by 97
Innate Immunity and Primary Biliary Cirrhosis: Activated Invariant Natural Killer T Cells Exacerbate Murine Autoimmune Cholangitis and Fibrosis §Δ
Wu, S.-J., Yang, Y., Tsuneyama, K., Leung, P. S. C., Illarionov, P. A., Gershwin, E. M., & Chuang, Y. (2010) · Hepatology · doi:10.1002/hep.24113 · Cited by 96
Biomarkers of alcohol consumption and related liver disease
Niemelä, O. J., & Alatalo, P. (2010) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2010.486442 · Cited by 95
Advances in Alcoholic Liver Disease
Beier, J. I., Arteel, G. E., & McClain, C. J. (2010) · Current Gastroenterology Reports · doi:10.1007/s11894-010-0157-5 · Cited by 98
Protective effects of curcumin against hepatic fibrosis induced by carbon tetrachloride: Modulation of high-mobility group box 1, Toll-like receptor 4 and 2 expression
Tu, C., Yao, Q., Xu, B., Wang, J., Zhou, C.-H., & Zhang, S. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.05.050 · Cited by 98
Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathway
Aoudjehane, L., Pissaia, A., Scatton, O., Podevin, P., Massault, P. P., Chouzenoux, S., Soubrane, O., Calmus, Y., & Conti, F. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.61 · Cited by 99
Global analysis of DNA methylation in early-stage liver fibrosis
Komatsu, Y., Waku, T., Iwasaki, N., Ono, W., Yamaguchi, C., & Yanagisawa, J. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-5 · Cited by 99
IL-30 (IL27p28) Attenuates Liver Fibrosis Through Inducing NKG2D-Rae1 Interaction Between NKT and Activated Hepatic Stellate Cells in Mice
Mitra, A., Satelli, A., Yan, J., Xueqing, X., Gagea, M., Hunter, C. A., Mishra, L., & Li, S. (2014) · Hepatology · doi:10.1002/hep.27392 · Cited by 94
In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations
Lee, Y., & Seki, E. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.05.010 · Cited by 102
Increased Angiogenesis Protects against Adipose Hypoxia and Fibrosis in Metabolic Disease-resistant 11β-Hydroxysteroid Dehydrogenase Type 1 (HSD1)-deficient Mice
Michailidou, Z., Turban, S., Miller, E., Zou, X., Schrader, J., Ratcliffe, P. J., Hadoke, P. W. F., Walker, B. R., Iredale, J. P., Morton, N. M., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.259325 · Cited by 98
Self-citation
The phenotypic fate and functional role for bone marrow-derived stem cells in liver fibrosis
Kisseleva, T., & Brenner, D. A. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.021 · Cited by 95
Emerging role of HMGB 1 in fibrotic diseases
Li, L., Gao, J., & Li, J. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12419 · Cited by 93
IL-13 Signaling in Liver Fibrogenesis
Liu, Y., Munker, S., Müllenbach, R., & Weng, H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00116 · Cited by 95
High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK
Wang, F.-P., Li, L., Li, J., Wang, J., Wang, L., & Jiang, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064373 · Cited by 91
Retracted
Combatting Fibrosis: Exosome‐Based Therapies in the Regression of Liver Fibrosis
Chen, L., Brenner, D. A., & Kisseleva, T. (2018) · Hepatology Communications · doi:10.1002/hep4.1290 · Cited by 93
Hepatic Stellate Cells and Liver Fibrosis
Puche, J. E., Saiman, Y., & Friedman, S. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00529.x · Cited by 89
The role of hypercoagulability in liver fibrogenesis
Anstee, Q. M., Dhar, A., & Thursz, M. R. (2011) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2011.03.011 · Cited by 89
Acidic Sphingomyelinase Controls Hepatic Stellate Cell Activation and in Vivo Liver Fibrogenesis
Moles, A., Tarrats, N., Morales, A., Domínguez, M., Bataller, R. A., Caballería, J., García‐Ruiz, C., Fernández-Checa, J. C., & Marı́, M. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091257 · Cited by 89
Autophagy fosters myofibroblast differentiation through MTORC2 activation and downstream upregulation of CTGF
Bernard, M., Dieudé, M., Yang, B., Hamelin, K., Underwood, K., & Hébert, M.-J. (2014) · Autophagy · doi:10.4161/15548627.2014.981786 · Cited by 86
Peroxisome proliferator-activated receptor-γ as a therapeutic target for hepatic fibrosis: from bench to bedside
Zhang, F., Kong, D., Lu, Y., & Zheng, S. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1046-x · Cited by 88
Myofibroblast progeny in wound biology and wound healing studies
Monika, P., Waiker, P. V., Chandraprabha, M. N., Rangarajan, A., & Murthy, K. N. C. (2021) · Wound Repair and Regeneration · doi:10.1111/wrr.12937 · Cited by 90
Lymphocytes Support Oval Cell-Dependent Liver Regeneration
Strick‐Marchand, H., Masse‐Ranson, G., Weiss, M. C., & Santo, J. P. D. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2764 · Cited by 88
Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking
Zhao, W., Yang, A., Chen, W., Wang, P., Liu, T., Cong, M., Xu, A., Yan, X., Jia, J., & You, H. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.01.019 · Cited by 84
Liver Tissue Engineering: Challenges and Opportunities
Agarwal, T., Subramanian, B., & Maiti, T. K. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b00745 · Cited by 83
Defining therapeutic targets for liver fibrosis: Exploiting the biology of inflammation and repair
Iredale, J. P. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.06.011 · Cited by 80
Self-citation
Stat3 signaling activation crosslinking of TGF-β1 in hepatic stellate cell exacerbates liver injury and fibrosis
Xu, M., Hu, J., Shen, J., Wang, M., Zhang, Q., Qu, Y., & Lu, L. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.025 · Cited by 84
Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription
Xu, B., Li, S.-H., Zheng, R. Q., Gao, S.-B., Ding, L., Yin, Z., Lin, X., Feng, Z.-J., Zhang, S., Wang, X., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312022110 · Cited by 82
Systemic treatment of advanced hepatocellular carcinoma: From disillusions to new horizons
Hollebecque, A., Malka, D., Ferté, C., Ducreux, M. P., & Boige, V. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2014.12.005 · Cited by 79
Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transition
Lee, S.-J. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i4.207 · Cited by 82
Inhibition of soluble epoxide hydrolase attenuates hepatic fibrosis and endoplasmic reticulum stress induced by carbon tetrachloride in mice
Harris, T. R., Bettaieb, A., Kodani, S. D., Dong, H., Myers, R., Chiamvimonvat, N., Haj, F. G., & Hammock, B. D. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.022 · Cited by 81
Parenchymal Extinction: Coagulation and Hepatic Fibrogenesis
Anstee, Q. M., Wright, M., Goldin, R. D., & Thursz, M. R. (2009) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.09.013 · Cited by 80
Increased MMP‐7 expression in biliary epithelium and serum underpins native liver fibrosis after successful portoenterostomy in biliary atresia
Kerola, A., Lampela, H., Lohi, J., Heikkilä, P., Mutanen, A., Hagström, J., Tervahartiala, T. I., Sorsa, T. A., Haglund, C. H., Jalanko, H., et al. (2016) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.50 · Cited by 79
Small molecule-mediated inhibition of myofibroblast transdifferentiation for the treatment of fibrosis
Bollong, M. J., Yang, B., Vergani, N., Beyer, B. A., Chin, E. N., Zambaldo, C., Wang, D., Chatterjee, A. K., Lairson, L. L., & Schultz, P. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702750114 · Cited by 78
Comparison of Two Protocols of Carbon Tetrachloride-Induced Cirrhosis in Rats – Improving Yield and Reproducibility
Fortea, J. I., Fernández-Mena, C., Puerto, M., Ripoll, C., Almagro, J., Bañares, J., Bellón, J. M., Bañares, R., & Vaquero, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-27427-9 · Cited by 79
Morin ameliorates chemically induced liver fibrosis in vivo and inhibits stellate cell proliferation in vitro by suppressing Wnt/β-catenin signaling
Perumal, M. K., Perumal, N., Samidurai, M., Devaraj, H., & NiranjaliDevaraj, S. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.03.008 · Cited by 79
Histone deacetylase 1 is required for transforming growth factor-β1-induced epithelial–mesenchymal transition
Lei, W., Zhang, K., Pan, X., Hu, Y., Wang, D., Yuan, X., Shu, G., & Song, J. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.006 · Cited by 78
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
Dyson, J. K., McPherson, S., & Anstee, Q. M. (2013) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2013-201620 · Cited by 78
Programmed cell death in hepatic fibrosis: current and perspectives
Lu, J.-L., Yu, C.-X., & Song, L.-J. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01749-8 · Cited by 81
M1- and M2-macrophage polarization in rat liver cirrhosis induced by thioacetamide (TAA), focusing on Iba1 and galectin-3
Wijesundera, K. K., Izawa, T., Tennakoon, A. H., Murakami, H., Golbar, H. M., Katou-Ichikawa, C., Tanaka, M., Kuwamura, M., & Yamate, J. (2014) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2014.04.003 · Cited by 77
Proteomic analysis of extracellular matrix from the hepatic stellate cell line LX-2 identifies CYR61 and Wnt-5a as novel constituents of fibrotic liver
Rashid, S. T., Humphries, J. D., Byron, A., Dhar, A., Askari, J. A., Selley, J. N., Knight, D., Goldin, R. D., Thursz, M. R., & Humphries, M. J. (2012) · Journal of Proteome Research · doi:10.1021/pr3000927 · Cited by 75

Authors: Iredale, J. P.
Affiliations: Centre for Inflammation Research (GB)
Corresponding author: Iredale, John P.
ORCID: Iredale, John P.
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 2007-03-01
Volume: 117
Issue: 3
Pages: 539-548
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci30542
PMC: PMC1804370
OpenAlex: W2120335459
Cited by: 866
References: 128
Citations by year: 2026: 19 · 2025: 40 · 2024: 45 · 2023: 39 · 2022: 32 · 2021: 39 · 2020: 34 · 2019: 36 · 2018: 39 · 2017: 36 · 2016: 51 · 2015: 63 · 2014: 61 · 2013: 57 · 2012: 55
FWCI: 7.58
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Funders: Wellcome Trust
Children's Liver Disease Foundation
Medical Research Council
Topics: Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Health Sciences › Medicine › Surgery › Wound Healing and Treatments
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Keywords: liver fibrosis, wound healing, inflammation, tissue repair, animal models, cell culture model, liver regeneration
MeSH terms: Animals, Disease Models, Animal, Extracellular Matrix, Fibroblasts, Humans, Inflammation, Liver Cirrhosis, Liver Cirrhosis, Experimental, Liver Regeneration, Models, Biological, Wound Healing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks